ASSLNIA, a peptide selected for murine myofibers using phage display technology, was immobilized onto an acoustic wave sensor. The sensor responded to murine and feline muscle homogenates indicating crosspieces interactions. Kidney, liver, and brain preparations produced insignificant responses.
The efficiency of drugs and therapeutic genes depends strongly on tissue-specific delivery. Identification of cell-specific binding ligands may be required for success in this approach. Development of ligands for many differentiated tissues such as mature muscle is limited by a lack of information on their cell-specific surface receptors. A solution to this problem can be found in the selection of ligands using phage display libraries, which is an approach requiring no prior knowledge of the target cell receptor expression and function [1] . However, in vivo screening protocol [2, 4] cannot be applied to humans, as the procedure requires euthanasia. Therefore, we have developed an in vitro assay to examine the cross-species properties of phage display derived peptide ligands. This method allows detection of ligand receptor interactions directly in tissue homogenates, opening the possibility to estimate the apparent affinity of peptides selected in animals to human tissues.
Peptide specific to murine skeletal muscle, ASSLNIA, was identified [4] by screening of a 7-mer phage display peptide library (New England Biolabs, Inc., Beverly, MA, USA). The peptide containing a GGGSK spacer added to C-terminus was synthesized, modified by coupling of a biotin molecule, and HPLC purified to 98% by Peptide Technologies Corporation (Gaithersburg, MD, USA). Samples of mouse and cat skeletal muscle, mouse kidney, liver and brain were harvested and tissue aliquots were homogenized in phosphate buffered saline (PBS). After homogenization samples were microcentrifuged for 10 min at 3000 rpm, and the supernatants containing tissue vesicles were separated from the pellets. Tissue homogenization resulted in the formation of vesicles, whose membranes are identical to the cell membrane. Vesicle concentration and integrity were examined by dark-field microscopy [3] . To perform the blocking experiment, free ASSLNIA peptide (1 mg/ml) synthesized by Research Genetics, Inc. (Huntsville, AL, USA) was added to murine muscle tissue homogenate (50 mg/ml) and incubated at room temperature for 1 h with agitation.
Monolayers containing biotinylated phospholipid (N(biotinoyl) -1,2 -dihexadecanoyl -sn -glycero -3 -phosphoethanolamine) were transferred onto the gold surface of an acoustic wave sensor using the Langmuir -Blodgett (LB) technique. Biotinylated peptide (ASSLNIAGGGSK-Biotin) was coupled with the phospholipid via streptavidin/biotin binding. The stable LB film [5] of biotinylated monolayers was treated for 2 h with streptavidin, diluted to a final concentration of 0.01 mg/ml in the subphase solution [5] , rinsed with distilled water, and dried for 2 min in ambient air. Then, the film was treated with the biotinylated peptide (0.001 mg/ml) in subphase solution for 2 h, rinsed and dried again as above.
Measurements were carried out using a PM-700 Maxtek plating monitor as previously described [5] . One ml PBS was delivered to the dry sensor surface and voltage was recorded for 4-8 min. Then PBS was removed and tissue homogenates of different dilutions were added sequentially to the sensor. Each experiment was replicated 2-4 times. Temperature of all samples was 25°C. The ratio of occupied (Y) and free (1− Y) peptide molecules on the sensor surface were analyzed by the Hill Plot [6] log
( 1) where K b is the association binding constant, C is a protein concentration in tissue homogenate, and n is the number of molecules bound to a single peptide. Fig. 1 shows the sensor response curves obtained by exposing the sensor to PBS containing different concentrations of the murine muscle homogenate. The initial time of the response (~1 =8 9 1 s) does not depend on the vesicle concentration. For each vesicle concentration the sensor signal approaches a steady-state value, corresponding to that concentration within 100 s (~2= 70 9 20 s). The response curves are distinguished by the fast reaction, the attainment of a steady state, and low non-specific binding [5] .
In Fig. 2 , upper curve, the mean values of the steady state output sensor voltages were plotted as a function of the relative concentration of the murine muscle homogenates. The interaction of the homogenate with the peptide was specific because preincubation of the murine muscle homogenate with free peptide resulted in significantly reduced signal (lower curve). When the b The apparent maximal surface concentration of protein, M max , was estimated from an increase of the sensor voltage assuming that the bound layer has a density 1 g/cm 3 . Fig. 3 . Cross-species specificity of the peptide selected for murine muscle. Hill plots. Points represent experimental data. Lines represent the least square fit of Eq. (1) with coefficients shown in Table 2 (for both lines R = 0.997, SD = 0.087, P B 0.0001). Fig. 4 . Selectivity of the muscle-specific peptide. Dose response plots were recorded with the peptide sensor exposed to murine muscle, kidney, and liver homogenates. Points represent experimental data of 2 -3 independent experiments. Lines represent the least square fit of Eq. (2) with coefficients shown in the footnote of While the amplitudes of the responses to the feline muscle homogenates were lower compared to those of the murine muscles ( Table 2 , Fig. 3 ), the same K d indicates that the peptide has cross-species affinity. As concluded from the value of the Hill coefficient, one binding site is needed to bind a single molecule to the sensor surface [6] . Fig. 4 shows selectivity of the sensor. The upper line represents the dose response of the peptide sensor to the murine muscle homogenate. Two lower lines show the dose responses of the peptide sensor to the murine liver and kidney homogenate. For any given concentration the sensor response for the muscle homogenate is greater than for liver or kidney. The voltage response (DV) as a function of protein concentration (C) is represented by the following empirical equation:
where C is the protein concentration in a tissue homogenate, A is the constant, and S is the slope of the dose response dependence, defined as the sensitivity of the sensor [7] . The selectivity coefficient for any tissue homogenate to the muscle homogenate (K) can be estimated from the voltage responses at different concentrations using a Table 3 Selectivity of the muscle-specific peptide b The activity ratio R Eq. (3) was calculated using experimental equations: DV muscle =0.593+0.134 log C; DV kidney =0.240+0.0418 log C; DV brain =0.296+0.0625 log C; DV liver = 0.260+0.0673 log C at the protein concentration in tissue homogenate equal to 0.01 mg/ml. c Phage selectivity was calculated from the binding of ASSLNIA phage to muscles, brain, liver, and kidney compared to the binding of control wild-type phage in vivo experiments in mice [4] . method similar to the matched potential method [7] . The selectivity coefficient (K) is defined as the activity ratio (R) of primary to interfering species (DC muscle / DC tissue ) that gives the same response change at the same condition. By using the definition of the selectivity coefficient and Eq. (2) the following is derived:
where S muscle and S tissue are slopes of voltage responses to muscle and another tissue (kidney, liver, or brain) homogenates. Table 3 illustrates the selectivity of the muscle-specific peptide. A marked response difference for the muscle homogenate is observed over all other tissues even when the concentrations of other tissues substantially exceed the concentration of the muscle homogenate. For example, the activity ratio for the muscle and kidney homogenates at 0.01 mg/ml is equal to 9.3×10 − 5 . This means that more than 100 mg/ml of the kidney homogenate is needed to induce the same response as induced by only 0.01 mg/ml of the muscle homogenate. Thus, the peptide sensor at these conditions selectively prefers muscle to kidney homogenates by factor of more than 10 000.
Novel delivery ligands can be selected in vivo in animals from phage display peptide libraries. In this study, we have designed the biosensor to quantify specific interactions of phage display derived peptides with a cell surface component of a tissue homogenate. It opens the possibility to examine the cross-species properties of the peptides and may accelerate their use as site-specific delivery vehicles in clinical applications.
